Providers/Grant Support
This activity is supported in part by an independent education grant from Pfizer and Bridgebio.
Credits Available
- Physicians—maximum of 1.0 AMA PRA Category 1 Credit™
All other health care professionals completing this course will be issued a statement of participation.
Target Audience
This activity is designed to meet the educational needs of clinicians (physicians, pharmacists, nurses, and other clinical professionals), including those specializing in cardiology (general cardiologists, heart failure nurses, heart failure specialists, echocardiographers, nuclear cardiologists, and electrophysiologists), primary care clinicians (MDs/DOs, NPs, and PAs), and other specialists who may encounter patients with potential or confirmed ATTR-CM, such as hospitalists, geriatricians, emergency medicine, and neurologists.
Program Overview
ATTR-CM is more common than many clinicians realize and more treatable than ever before but diagnosis is still often missed or delayed. In this case-based activity you’ll learn how to identify high-risk patients, order and interpret genetic tests and guide patients through the emotional and clinical decisions that follow. Explore how race, age, and family history shape the diagnostic process and why understanding the difference between wild-type and hereditary ATTR-CM matters more than ever.
Learning Objectives
Upon completion of this activity, participants should be better able to:
- Identify patients with heart failure who should be assessed for possible amyloidosis work-up
- Describe to patients with ATTR-CM how genetic testing may impact their disease management
- Outline the steps and available resources for genetic testing for patients with ATTR-CM
Faculty
Kevin M. Alexander, MD
Assistant Professor
Stanford Amyloid Center
Stanford University
Palo Alto, CA
Emily Brown, MGC, CGC
Genetic Counselor IV
Johns Hopkins University
Baltimore, MD
Newton B. Wiggins, MD, FACC, FHRS
Cardiologist
Common Spirit Health
Chattanooga, TN
Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by The France Foundation and the National Society of Genetic Counselors . The France Foundation is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation
The France Foundation designates this enduring activity for a maximum of 1.0 AMA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
Disclosures of Conflict of Interest
Emily Brown, MGC, CGC–Planning Committee
Non-CE consulting for Grey Genetics
All final planning decisions concerning content, learning objectives, and evaluation questions were made by the non-conflicted planning committee chair.
Kevin Alexander, MD, FACC, FHFSA–Planning Committee, Faculty
Non-CE consulting for Arbor Biotechnologies, Attralus, Novo Nordisk, Pfizer, and Prothena Biosciences
All final planning decisions concerning content, learning objectives, and evaluation questions were made by a non-conflicted planning committee chair.
Newton Wiggins, MD, FACC, FHRS–Planning Committee
No relevant financial disclosures
Emily Perkins–TFF Staff
No relevant financial disclosures
Margaret Das, PhD–TFF Staff
No relevant financial disclosures
Heather Tarbox, MPH–TFF Staff
No relevant financial disclosures
Instructions for Participation and Credit
There are no fees for participating and receiving CME credit for this enduring activity. To receive CME credit participants must:
- Read the CME/CE information and faculty disclosures
- Participate in the online activity
- Submit the evaluation form
Certificates will be emailed to the participant.
Course Viewing Requirements
Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, and Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above
Disclosure of Unlabeled Use
The France Foundation requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
Disclaimer
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
Contact Information
For CME questions please contact: [email protected]